Enovis Corp Other Depreciation and Amortization
Enovis Corp (ENOV) reported Other Depreciation and Amortization of $29.47 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherDepreciationAndAmortization · last filed 2026-08-06
- Enovis Corp other depreciation and amortization for the quarter ending 2026-07-03 was $29.47M, a 3.08% increase year-over-year.
- Enovis Corp other depreciation and amortization for the quarter ending 2026-04-03 was $31.45M, a 6.16% increase year-over-year.
- Enovis Corp other depreciation and amortization for the quarter ending 2025-12-31 was $31.82M, a 0.84% increase year-over-year.
- Enovis Corp other depreciation and amortization for the quarter ending 2025-10-03 was $30.69M, a 7.91% increase year-over-year.
- Enovis Corp other depreciation and amortization for fiscal 2025 was $120.72M, a 2.92% increase from fiscal 2024.
- Enovis Corp other depreciation and amortization for fiscal 2024 was $117.30M, a 40.32% increase from fiscal 2023.
- Enovis Corp other depreciation and amortization for fiscal 2023 was $83.59M, a 9.04% increase from fiscal 2022.
- Enovis Corp other depreciation and amortization for fiscal 2022 was $76.66M, a 9.41% increase from fiscal 2021.
| Period end | Other Depreciation and Amortization 3 month | Other Depreciation and Amortization 6 month | Other Depreciation and Amortization 9 month | Other Depreciation and Amortization 12 month |
|---|---|---|---|---|
| 2026-07-03 | $29.47M 10-Q · filed 2026-08-06 | $60.92M 10-Q · filed 2026-08-06 | $92.74M derived: sum of 3 quarters · filed 2026-08-06 | $123.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-04-03 | $31.45M 10-Q · filed 2026-05-07 | $63.27M derived: sum of 2 quarters · filed 2026-05-07 | $93.96M derived: sum of 3 quarters · filed 2026-05-07 | $122.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $31.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $62.51M derived: sum of 2 quarters · filed 2026-02-26 | $91.10M derived: sum of 3 quarters · filed 2026-08-06 | $120.72M 10-K · filed 2026-02-26 |
| 2025-10-03 | $30.69M 10-Q · filed 2025-11-06 | $59.28M derived: sum of 2 quarters · filed 2026-08-06 | $88.90M 10-Q · filed 2025-11-06 | $120.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-07-04 | $28.59M 10-Q · filed 2026-08-06 | $58.21M 10-Q · filed 2026-08-06 | $89.77M derived: sum of 3 quarters · filed 2026-08-06 | $118.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-04-04 | $29.62M 10-Q · filed 2026-05-07 | $61.18M derived: sum of 2 quarters · filed 2026-05-07 | $89.62M derived: sum of 3 quarters · filed 2026-05-07 | $119.75M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $31.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $60.00M derived: sum of 2 quarters · filed 2026-02-26 | $90.13M derived: sum of 3 quarters · filed 2026-02-26 | $117.30M 10-K · filed 2026-02-26 |
| 2024-09-27 | $28.44M 10-Q · filed 2025-11-06 | $58.57M derived: sum of 2 quarters · filed 2025-11-06 | $85.74M 10-Q · filed 2025-11-06 | $107.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-28 | $30.13M 10-Q · filed 2025-08-07 | $57.30M 10-Q · filed 2025-08-07 | $78.66M derived: sum of 3 quarters · filed 2026-02-26 | $100.15M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-29 | $27.17M 10-Q · filed 2025-05-08 | $48.53M derived: sum of 2 quarters · filed 2026-02-26 | $70.02M derived: sum of 3 quarters · filed 2026-02-26 | $90.81M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $21.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.85M derived: sum of 2 quarters · filed 2026-02-26 | $63.64M derived: sum of 3 quarters · filed 2026-02-26 | $83.59M 10-K · filed 2026-02-26 |
| 2023-09-29 | $21.49M 10-Q · filed 2024-11-06 | $42.29M derived: sum of 2 quarters · filed 2024-11-06 | $62.24M 10-Q · filed 2024-11-06 | $82.79M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $20.79M 10-Q · filed 2024-08-07 | $40.74M 10-Q · filed 2024-08-07 | $61.30M derived: sum of 3 quarters · filed 2025-02-26 | $79.46M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $19.95M 10-Q · filed 2024-05-02 | $40.51M derived: sum of 2 quarters · filed 2025-02-26 | $58.66M derived: sum of 3 quarters · filed 2025-02-26 | $78.11M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $20.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $38.71M derived: sum of 2 quarters · filed 2025-02-26 | $58.16M derived: sum of 3 quarters · filed 2025-02-26 | $76.66M 10-K · filed 2025-02-26 |
| 2022-09-30 | $18.16M 10-Q · filed 2023-11-07 | $37.61M derived: sum of 2 quarters · filed 2023-11-07 | $56.11M 10-Q · filed 2023-11-07 | $74.54M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-07-01 | $19.45M 10-Q · filed 2023-08-03 | $37.95M 10-Q · filed 2023-08-03 | $56.38M derived: sum of 3 quarters · filed 2024-02-22 | $74.78M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-04-01 | $18.50M 10-Q · filed 2023-05-04 | $36.93M derived: sum of 2 quarters · filed 2024-02-22 | $55.33M derived: sum of 3 quarters · filed 2024-02-22 | $71.68M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $18.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $36.83M derived: sum of 2 quarters · filed 2024-02-22 | $53.18M derived: sum of 3 quarters · filed 2024-02-22 | $70.07M 10-K · filed 2024-02-22 |
| 2021-10-01 | $18.40M 10-Q · filed 2022-11-02 | $34.75M derived: sum of 2 quarters · filed 2022-11-02 | $51.64M 10-Q · filed 2022-11-02 | |
| 2021-07-02 | $16.35M 10-Q · filed 2022-08-04 | $33.24M 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | $64.60M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |